News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lupin Ltd. (LUPN.BO) Sets up R&D in U.S., Ropes in Teva Pharmaceutical Industries Limited (TEVA), Sandoz, Inc. Executives


8/12/2013 7:16:44 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Lupin, the country’s third largest pharmaceutical company, has just begun setting up a research and development (R&D) centre in the US, but the R&D head of Teva Pharmaceuticals and another top official from Sandoz, the generic pharmaceuticals division of global industry leader Novartis, are on board already. Lupin is identifying other key officials and expects to get the R&D centre operational around August next year. Vinita Gupta, CEO of Lupin, said the company started working on the US R&D project six months ago. “It’s a work in progress.

Help employers find you! Check out all the jobs and post your resume.

Read at DNA India


comments powered by Disqus
DNA India
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES